It has been shown that the inhibition of CXCL12/CXCR4 signaling pathway, in combination with radiotherapy, decreased myeloid cells' infiltration; delayed tumor progression and ultimately led to anti-glioma immunological memory (40). This evidence concerns the gene CXCL12 and central nervous system cancer.